SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Odonate Therapeutics Q2 EPS $(1.09) Up From $(1.15) YoY

Odonate Therapeutics (NASDAQ:ODT) reported quarterly losses of $(1.09) per share. This is a 5.22 percent increase over losses of $(1.15) per share from the same period last year.

Benzinga · -
Odonate Therapeutics (NASDAQ: ODT) reported quarterly losses of $(1.09) per share. This is a 5.22 percent increase over losses of $(1.15) per share from the same period last year.